Prestige Brand Holdings Inc logo

Prestige Brand Holdings Inc(PBH)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
SELL
SELL for 3 days
PROFIT SINCE LAST BUY
-19.33% ▼
LAST CLOSE
$44.97
11/10/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for PBH

11/10/2026: PBH (1-star) is a SELL. SELL for 3 days. Simulated Profits (-19.33%). Updated daily EoD!

Prestige Consumer Healthcare Inc. is a focused marketer and distributor of over-the-counter health and household products. The company has a leading position in niche categories like pain relief and eye care, leveraging well-known heritage brands to generate steady cash flow. Its primary investment story centers on disciplined brand management and opportunistic acquisitions that enhance operational margins. However, the company faces significant competition from lower-priced private label alternatives and must carefully manage its historical debt load. The stock may best suit value-oriented investors who prioritize stable cash generation, though those seeking dividend income or high-growth momentum may find other options more appropriate for their portfolios.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitThe company's business model is centered on brand maintenance and cash flow rather than rapid revenue expansion.
Momentum investorMixed fitThe stock tends to trade based on M&A news and broader consumer health sector sentiment.
Value investorStrong fitConsistent cash generation and predictable business models often appeal to value-oriented investors.
Dividend investorWeak fitThe company does not currently pay a dividend, making it unsuitable for income-seeking portfolios.
Low-risk investorMixed fitWhile the products are staples, the high leverage and sector competition introduce moderate risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumThe stock can be sensitive to market-wide shifts in the consumer staples sector.
Valuation riskMediumMarket pricing relies on the company's ability to continue acquiring and growing brands efficiently.
Competition riskHighPrivate label expansion significantly threatens the margins of heritage OTC brands.
Business qualityMediumThe portfolio consists of established brands, providing a stable but mature business profile.
Dividend incomeLow / noneThe absence of a dividend limits the appeal for income-focused investors.
Execution riskMediumSuccessful growth is highly dependent on managing debt and identifying accretive acquisition targets.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit -29.12%
Avg. Invested days 35
Today’s Advisory SELL
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/10/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
PBH receives a 4-star rating, supported by strong unit economics, solid company fundamentals, and solid analyst coverage. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
PBH has solid overall fundamentals (4 stars), with solid financial health, moderate growth momentum, and solid ownership. In FY2026 versus FY2025, strong cash generation (FCF margin 22.6%) and solid profitability (net margin 17.5%) are partially offset by negative earnings growth (-11.3%), slightly negative revenue growth (-4.3%), modest insider ownership of 1.41%.

Financial Health Rating

★★★★★
PBH's financial health is supported by solid cash strength, including free-cash-flow generation (22.6% of revenue). Liquidity is moderate (3 stars), which helps explain the 4-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is PBH's strongest growth driver at +1.3% FY2026 versus FY2025 (moderate, 3 stars). By comparison, while revenue growth (-4.3%, slightly negative) and earnings growth (-11.3%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 115.1% and approximately 98.6% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 1.41% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 16.52%
Ariel Investments, LLC 10.27%
Vanguard Portfolio Management, LLC 5.96%
Dimensional Fund Advisors, Inc. 5.59%
Fuller & Thaler Asset Management Inc 4.92%

Unit Economics (Per $1K Revenue)

★★★★★
PBH generates approximately $528 of gross profit, $284 of operating income, and $226 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Strong margins and strong cash conversion support the rating, although capital efficiency remains soft.

Economic Dimensions

★★★★★
Effective Tax Rate: 26.10%

Quantitative Style Profile

★★★★★
PBH has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.13B USD
Price to earnings Ratio 13.88
1Y Target Price 66.2
Price to earnings Ratio 13.88
1Y Target Price 66.2
Volume (30-day avg) 613.5K shares
Beta 0.29
52 Weeks Range 41.77 - 71.07
Updated Date 11/10/2026
52 Weeks Range 41.77 - 71.07
Updated Date 11/10/2026
Dividends yield (FY) -
Basic EPS (TTM) 3.24

How Company Makes Money

Business areaWhat it includesRetail investor read
OTC HealthcarePain relief, women's health, and eye care products like Monistat and Clear Eyes.The company earns money by selling everyday health products that people frequently need.
Household CleaningSpecialty cleaners and home maintenance items.This segment provides steady, predictable income from household staple goods.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-05
When Before Market
Estimate 1.06
Actual 1.13

Profitability

Profit Margin 13.29%
Operating Margin (TTM) 24%

Management Effectiveness

Return on Assets (TTM) 4.72%
Return on Equity (TTM) 8.23%

Valuation

Trailing PE 13.88
Forward PE 9.53
Enterprise Value 4.15B
Price to Sales(TTM) 1.83
Enterprise Value 4.15B
Price to Sales(TTM) 1.83
Enterprise Value to Revenue 3.56
Enterprise Value to EBITDA 13.16
Shares Outstanding 47.40M
Shares Floating 46.72M
Shares Outstanding 47.40M
Shares Floating 46.72M
Percent Insiders 1.41
Percent Institutions 115.13

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.